CAS
SKYE icon

Coppell Advisory Solutions’s Skye Bioscience SKYE Stock Holding History

Coppell Advisory Solutions’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4
Closed -$4 – 1949
2024
Q4 		$4 Buy
+4
New +$17 ﹤0.01% 1973

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Coppell Advisory Solutions's SKYE Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Skye Bioscience (SKYE) in Q1 2025, closing a stake of 4 shares — an estimated $4 sold.

Coppell Advisory Solutions first reported a position in SKYE in Q4 2024 and held it in 1 quarter. The position peaked at $4 in Q4 2024. 75 funds tracked by Wall St. Rank hold SKYE as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Skye Bioscience position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 4 Skye Bioscience shares in Q1 2025, an estimated $4.
  • Coppell Advisory Solutions first reported a position in Skye Bioscience in Q4 2024 and held it in 1 quarter.
  • Coppell Advisory Solutions's Skye Bioscience position peaked at $4 in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.